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InfectivityEnterovirus 71 (EV71) is a major cause of hand-foot-and-mouth disease. EV71 infection occasionally associates
with severe neurological sequelae such as brainstem encephalitis or poliovirus-like paralysis. We demonstrated
that mouse-adapted strain increases infectivity, resulting in higher cytotoxicity of neuron cells and mortality to
neonatalmice than a non-adapted strain. Results pointed to EV71 capsid region determining viral infectivity and
mouse lethality. Mutant virus with lysine to methionine substitution at VP2149 (VP2149M) or glutamine to gluta-
mic acid substitution at VP1145 (VP1145E) showed greater viral titers and apoptosis. Synergistic effect of VP2149M
and VP1145E doublemutations enhanced viral binding and RNA accumulation in infectedNeuro-2a cells. The dual
substitutionmutantsmarkedly reduced value of 50% lethal dose in neonatalmice infection, indicating they raised
mouse lethality in vivo. In sum, VP2149M and VP1145E mutations cooperatively promote viral binding and RNA ac-
cumulation of EV71, contributing to viral infectivity in vitro and mouse lethality in vivo.
Crown Copyright © 2011 Published by Elsevier Inc. All rights reserved.Introduction
Enterovirus 71 (EV71), belongs to the species human enterovirus A,
genus Enterovirus, family Picornaviridae, with positive single strand
RNA genome. Since it was ﬁrst isolated and characterized from a neu-
rological disease case in California (Schmidt et al., 1974), many other
EV71 outbreaks have been reported worldwide (Hsiung, 1993; Liu et
al., 2000). Infection followed an epidemic mode of transmission,
caused pandemics or outbreaks and then became dominant around
the Asia–Paciﬁc region in recent years (Hosoya et al., 2006). An
EV71-associated hand, foot, and mouth disease (HFMD) outbreak
with 30 fatalities occurred in Sarawak, Malaysia, as of 1997, followed
by another severe outbreak during 1998 in Taiwan. The latter caused
severe complications for 405 children: e.g., encephalitis, aseptic men-
ingitis, pulmonary edema or hemorrhage, acute ﬂaccid paralysis,
myocarditis, and 78 deaths (AbuBakar et al., 1999; Chang et al.,
1999; Ho, 2000; Huang et al., 1999; Lin et al., 2002). Outbreaks con-
tinue to occur worldwide: Japan in 1997; Perth in 1999; Singapore,
Korea, Malaysia, and Taiwan in 2000–2001 (Ho et al., 1999; McMinn
et al., 2001; Shimizu et al., 1999;Wang et al., 2002). In 2003–2004 an-
other wave of HFMD-associated outbreaks hit Korea, Japan, andboratory Science and Biotech-
ty Road, Tainan, 701, Taiwan.
g).
11 Published by Elsevier Inc. All righTaiwan (Hosoya et al., 2006; Jee et al., 2003; Lin et al., 2006). In
2007–2008, HFMD outbreaks reemerged in China with fatalities
(Yang et al., 2009; Yu et al., 2010; Zhang et al., 2009, 2010) and
spawned a separate epidemic in Taiwan (Huang et al., 2009).
According to phylogenic analysis of VP1 protein coding region, EV71
viruses can be segregated into genotypes A, B, and C (Brown et al.,
1999); genotypes B and C include subtypes B1–B5 and C1–C5. Evolution
studies, which estimate diverse subgenotypes' dates of origin, suggest
emergent virus usually appearing one to ﬁve years before anHFMDout-
break and reveal a ladder-like pattern with continuous strain replace-
ment (Mirand et al., 2010; Tee et al., 2010). Genetic evolutionary
changes yield diverse traits like antigenic properties. Prior analysis of
neutralization antibody in human antisera from EV71 patients showed
diverse antigenic properties among subgenotypes B1/B4, C2/C4 and dis-
tinct cluster of B5, dominant in Taiwan's 2008 outbreak (Huang et al.,
2009). Antigenic difference between genotypes of EV71 was also
reported by van der Sanden et al., ﬁnding B2 rabbit antiserum can neu-
tralize genotypes B0, B1, and B2 with high average titers but react with
genotypes C1, C2, and A with lower ones (Van der Sanden et al., 2010).
Available evidence suggests encephalitic viruses inducing higher
cytotoxicity and cell apoptosis than non-encephalitic viruses in neu-
ronal cells (Shahar et al., 1992). Earlier reports indicate various
EV71 strains as dermatotropic or neurotropic (Ishimaru et al.,
1980). Liu et al. claimed that whether EV71 strains in the 1998 out-
break were dermatotropic or neurotropic may correlate with clinical
presentation (Liu et al., 2000). Wen et al. proved that EV71 straints reserved.
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several mammalian cell lines (Wen et al., 2003). Mounting evidence
points to correlation between viral cytotoxicity in neuronal cells
and neurological disease. Diverse clinical presentations are supposed-
ly caused by host factors and, mostly, virulence of different strains
(Ishimaru et al., 1980; Melnick, 1984), prompting us to identify
virus determinants of EV71 responsible for infectivity and cytotoxicity
of EV71 strains.
In prior study, mouse-adapted EV71 strain MP4 exhibited lower le-
thal dose than 4643 for intraperitoneal infection model in neonatal
mice (Wang et al., 2004). MP4 enhanced neuronal cell apoptosis and
viral growth on RD, SK-N-SH, and Caco-2 cells than parental 4643
strains in vitro. MP4 strain had a larger plaque size and grew more
temperature-resistant when compared with parental 4643 strain.
MP4-infected mice showed higher virus titers and growth kinetics in
central nerve system tissue and other organs than 4643 strain; apopto-
sis of spinal cord and brain stem neurons was likewise identiﬁed.
According to sequence analysis, a dozen point mutations arose in 5′-Fig. 1.MP4 viruses show higher cytotoxicity than 4643. Neuro-2a, RD, Vero, and A549 cells w
portion was indicated after staining with Annexin V-FITC and PI. Data expressed as mean±UTR, VP2, VP1, 2C, and 3C regions of MP4 strain when compared with
4643 strain (Wang et al., 2004). This study investigated MP4 infectivity
determinants resulting in higher cytotoxicity in the whole genome. We
further evaluated their effect on mouse fatality in vivo plus correlation
among virus infectivity, cytotoxicity, and mouse lethality.
Results
Capsid-coding region of mouse-adapted MP4 strain determined in vitro
infectivity
To test cytotoxicity of 4643 andmouse-adaptedMP4, mouse neuro-
blastoma Neuro-2a, human rhabdomyosarcoma RD, African Green
Monkey epithelium Vero, and human epithelium A549 cells were
infectedwith recombinant 4643 andMP4 atmoi of 0.1. Viral cytotoxcity
was plotted by ratio of apoptotic cells with annexin V and PI staining.
Neuro-2a results showed 21.63% and 88.19% annexin V positive cells
of 4643 and MP4 recombinant virus-infected cells as of Day 5 post-ere infected with 4643 and MP4 recombinant viruses at moi of 0.1. Apoptotic cell pro-
SD of each group (n=3) from one representative experiment.
Fig. 2. Capsid proteins contributed to infectivity and cytotoxicity in vitro. (a) Schematic
diagram of recombinant EV71 viruses, names designated by nomenclature, indicating
origin of 5′ UTR, capsid protein coding region, and nonstructural protein coding region
with 3′ UTR origin from 4643 (4) or MP4 (M) strain, respectively. Neuro-2a cells were
infected with various recombinant viruses at moi of 0.1 for 5 days. To rate infectivity
and cytotoxicity, virus titers and apoptotic cells following virus infection were deter-
mined by plaque assay and annexin V staining, respectively. Results showed infectivity
(b) and cytotoxicity (c) of various recombinant viruses in Neuro-2a cells. Data were
expressed as mean±SD of each group (n=3) from one representative experiment.
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curredwith reported human neuronal cell SK-N-SH, as described earlier
(Wang et al., 2004). We found MP4 infection causing more infectivity
according to viral protein expression, which led to greater cytotoxicity
than 4643 in RD and Vero cells by capsid protein and annexin V double
staining at Days 3 and 4 post-infection, respectively; no apoptosis of
A549 cells was detected in a 5-day interval (Supplemental Fig. 1a). As
for 4643 versus MP4 cytotoxicity, we calculated percentage of annexin
V positive cells per EV71 infected cell according to results in Supple-
mental Fig. 1a to ﬁnd MP4 mouse-adapted virus showing higher
Annexin V(+)/EV71(+) ratio than non-adapted 4643 virus in Neuro-
2a and Vero cells (Supplemental Fig. 1b). We concluded that MP4
showed higher infectivity, causing cytotoxicity not only in murine
Neuro-2a but also in primate Vero cells in vitro.
Variable gene regions, including the untranslated, capsid protein
coding, and nonstructural protein coding regions, were previously
found to support virus-induced apoptosis, virus replication, and interac-
tions with cellular factors for virus growth (Arita et al., 2005; Kuo et al.,
2002; Li et al., 2002; Lin et al., 2008, 2009; Nishimura et al., 2009; Tang
et al., 2007; Yamayoshi et al., 2009; Yeo and Chow, 2007). Next, we tried
to determinewhichMP4 genetic region affects virus infectivity and viral
cytotoxicity by examining virus titers and apoptotic cells in vitro.
Two series of recombinant 4643 and MP4 viruses by mutually ex-
changing the 5′ untranslated region (UTR), capsid protein coding re-
gion, or non-structural protein coding region/3′ UTR were prepared.
According to the order from 5′ to 3′ terminus in virus genome struc-
ture and origin of 5′ UTR, the capsid protein coding region, or non-
structural protein coding region/3′ UTR from 4643 (4) or MP4 (M),
recombinant viruses were designated M44, 4MM, 4M4, M4M, MM4,
and 44M (Fig. 2a). Then various recombinant EV71 virus infections
in Neuro-2a cells and mice were probed. Genome exchange in capsid
protein coding region (4M4 virus) revealed high virus titer similar to
that of MP4 (Fig. 2b). Titers of virus containing 5′ UTR of MP4 (M44)
resembled those of MP4 virus in Neuro-2a cells, proving that capsid
protein coding region as well as 5′ UTR both contribute to high viral
replication. Among MP4 series of recombinant viruses, only M4M, in
which the MP4 capsid protein coding region was exchanged with
4643, showed reduced virus titers. Nonetheless, exchanging the
other two regions of MP4 virus with 4643 (4MM and MM4) did not
affect virus titer.
As a result of increasing virus titer, capsid protein coding region of
MP4 also contributed to apoptosis cell elevation in Neuro-2a cells
(Fig. 2c). Among the 4643 series of recombinant viruses, those that
contained 5′ UTR and non-structural protein coding region/3′ UTR re-
gions of MP4 such as M44 and 44M, exhibited limited cytotoxicity;
still, as capsid protein coding region was obtained from MP4, 4M4
virus robustly increased ability of 4643 to induce Neuro-2a cell apo-
ptosis similar to MP4 (Fig. 2c). We conversely examined cytotoxicity
of the recombinant MP4 virus series as well to highlight the role of
the capsid protein coding region; only M4M, which contained capsid
protein coding region from 4643, exhibited substantially low cytotox-
icity. As for recombinants 4MM and MM4, only MM4 that exchanged
non-structural protein coding region/3′ UTR regions with 4643
showed slight reduction of cytotoxicity (Fig. 2c). Together, capsid
protein coding region determined not only virus infectivity but also
viral cytotoxicity of MP4 in Neuro-2a cells in vitro.
Identiﬁcation of VP2149M and VP1145E contributed to in vitro viral
infectivity
To identify determinants of MP4 viral infectivity in vitro, we se-
quenced the 4643 and MP4 clones and compared their sequences in
capsid protein coding region. Ten nucleotide substitutions were iden-
tiﬁed, three resulting in amino acid sequence changes (Table 1): A to
T at nucleotide position (nt.) 1398 in VP2149 (amino acid substitution
from lysine to methionine), C to G at nt. 2873 in VP1145 (glutamine toglutamic acid), and T to C at nt. 3288 in VP1283 (phenylalanine to
serine).
Since amino acidmutationmay alter properties of VP2 or VP1 capsid
proteins, we hypothesized that three substitutionsmight determine in-
fectivity resulting in cytotoxicity in vitro. To test our hypothesis, wemu-
tated VP2149, VP1145, and VP1283 residues of the 4643 wild-type virus
into methionine, glutamic acid, and serine, respectively (Fig. 3a), and
rated their effects on infectivity by examining virus titers and cytotoxic-
ity of these recombinants at moi 0.1. Either VP2149M or VP1145E muta-
tions independently raised virus titers of Neuro-2a cells; recombinant
4643 containing mutation VP2149M (4643 VP2149M virus) or VP1145E
(4643 VP1145E virus) but not VP1283S (4643 VP1283S virus) showed
high virus titers onDay 5 post-infection (Fig. 3b). The VP2149Mmutation
was found to increase virus titers in Neuro-2a cells similar to VP1145E,
whereas only VP2149M and VP1145E dual mutations increased both of
virus titers and cytotoxicity like MP4 virus (Figs. 3b and c). Converse
mutations VP2149K, VP1145Q, or VP1283F were introduced into MP4
wild-type virus as well. Only MP4 with VP2149K+VP1145Q double
Table 1
Sequence comparison of 4643 and MP4 infectious cDNA clones.
Region Nucleotide sequence Amino acid sequence
Position 4643 MP4 Position 4643 MP4
5′UTR 40 C T –
307 C T –
498 A G –
577 C T –
691 T C –
VP4 757 A G –
817 T A –
VP2 982 C T –
1093 T C –
1398 A T 149 K M
VP3 1735 A G –
VP1 2662 T C –
2873 C G 145 Q E
2965 T C –
3288 T C 283 F S
2A 3547 T C –
2B 4051 C T –
2C 4324 T C –
4985 G T 302 V L
3A 5110 G A –
5135 T C –
5254 G A –
3C 5555 A G 55 I V
3D 6007 T A –
6388 G A –
6478 T C –
6541 C T –
6556 T C –
6574 T C –
6613 T C –
6625 T C –
6817 C T –
7261 A G –
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virus (Figs. 3b and c). This suggests amino acid residues methionine in
VP2149 and glutamic acid in VP1145 as cooperatively responsible for in-
fectivity which results in cytotoxicity of MP4 virus in vitro.
To clarify the role of VP2149M and VP1145E mutation, we examined
infectivity and cytotoxicity of recombinant 4643 virus-infected Neuro-
2a cells by double staining of capsid protein and annexin V at moi of
10, respectively. Results showed a high ratio of double stain positive
Neuro-2a cells in 4643 VP2149M+VP1145E virus-infected cells on Day
3 post-infection (Supplemental Fig. 2a); on Day 4 we detected higher
numbers of capsid protein-positive or double-stain-positive cells in
4643 VP2149M virus infection, and in 4643 VP1145E virus infected cells
on the ﬁfth day. According to results of annexin V and EV71 antigen
double staining, we compared cytotoxicity of VP2149M and/or VP1145E
mutant viruses by calculating the ratio of annexin V-positive to EV71
infected cells. We found 4643 VP2149M+VP1145E virus with a higher
ratio of Annexin V(+)/EV71(+) than 4643 virus in Neuro-2a cells at
Days 4–5 post-infection (Supplemental Fig. 2b). These indicated
VP2149M+VP1145E mutant virus, similar to MP4 (Supplemental
Fig. 1b), exhibiting higher cytotoxicity than 4643 virus as a result of
higher infectivity of 4643 VP2149M+VP1145E in mouse Neuro-2a cells.
In addition, we determined kinetics of virus growth at low moi (moi
0.01) in Neuro-2a cells (Supplemental Fig. 3). Recombinant 4643
VP2149M VP1145E virus exhibited signiﬁcant increased virus titers on
post-infection, followed by recombinant virus of 4643 VP2149M or
4643 VP1145E, which increased a day later; those of 4643 virus did not
change over four days. VP2149M and/or VP1145Emutation heightened in-
fectivity to Neuro-2a cells, with greater cytotoxicity when compared to
parental 4643 virus.
Previous results showed MP4 virus forming large plaques in con-
trast to those produced by 4643 virus (Wang et al., 2004). Recombi-
nant 4643 containing VP2149M and VP1145E mutations individuallyand in tandem presented large plaques similar to MP4 wild-type,
but 4643 virus containing VP1283S mutation exhibited small plaques,
suggesting that VP2149M and VP1145E mutations spurred growth and
spread of MP4 virus (Fig. 4). MP4 recombinants containing VP2149K,
VP1283F, or VP2149K+VP1145Q double mutations, formed smaller pla-
ques compared to that of MP4 wild-type. By contrast, VP1145Q muta-
tion alone did not reduce plaque size of MP4, hinting that while
mutation(s) in other regions may co-contribute to MP4 plaque size,
methionine in VP2149 and glutamic acid in VP1145 increased its
growth and spread.
VP1145E and VP2149M mutations cooperatively enhanced EV71 RNA accu-
mulation in Neuro-2a cells
As for components of capsid subunits, VP1 and VP2 proteins ex-
hibit interaction between enterovirus and its cellular receptor (Ross-
mann et al., 1985). It is thus possible that VP2149M and VP1145E
mutations changed EV71 binding ability to Neuro-2a cells. To test
for this, recombinants 4643 with VP2149M and/or VP1145E mutations
and MP4, as a positive control group, were absorbed to Neuro-2a
cells and the capsid protein binding to Neuro-2a cells determined
by ELISA (Fig. 5). We found that VP1145E mutation increased percent-
age of binding virus. In addition, recombinant 4643 virus that con-
tained both VP2149M and VP1145E mutations, as well as MP4 virus,
showed increased binding to Neuro-2a cells in contrast to 4643
wild-type virus. Yet single VP2149M mutation did not increased bind-
ing to cells. This result highlighted the virus binding to Neuro-2a cells
enhanced by VP1145E mutation.
To ascertain whether additional steps were affected by dual muta-
tions, we measured EV71 RNA amount in Neuro-2a cells infected by
viruses with VP2149M and/or VP1145E mutation at moi 100 and
amount of 18S ribosomal RNA as control (Fig. 6a). As of 12 h post-
infection, viral RNA of 4643 VP2149M and 4643 VP2149M+VP1145E
virus-infected Neuro-2a cells increased, as compared to viral RNA of
4643 virus-infected cells. As of 24 h post-infection, approximately
134-fold robust increase of viral RNA appeared in 4643 VP2149M+
VP1145E virus-infected cells (Fig. 6a). We also examined virus titers
by plaque assay and obtained similar results: those of 4643 VP2149M
VP1145E virus robustly increased in Neuro-2a cells at moi 100
(Fig. 6b), suggesting VP2149M and VP1145E cooperatively raising RNA
accumulation and viral growth of EV71 in Neuro-2a cells. Data
highlighted RNA accumulation due to EV71 infection of Neuro-2a
cells as synergistically enhanced by both mutations.
Besides measuring EV71 RNA amount in Neuro-2a cells infected
by viruses with VP2149M and/or VP1145E mutations, various recombi-
nant 4643 RNAs containing VP1145E and/or VP2149M mutations were
transfected into Neuro-2a and RD cells to bypass viral entry via cellu-
lar receptors. Total RNA was extracted to determine EV71 RNA accu-
mulation at indicated post-transfection times. In mouse
neuroblastoma Neuro-2a cells, 4643 RNA, 4643 with VP2149M and
4643 with VP1145E had less than 10-fold increase between post-
transfection 0 to 24 h (Fig. 6c). By contrast, 4643 VP2149M+VP1145E
RNA exhibited abundant viral RNA: approximately 29- and 50-fold in-
crease at 16 and 24 h post-transfection, respectively. Similar results
were seen in rhabdomyosarcoma cells (data not shown), indicating
presence of such mutations further increasing viral RNA besides en-
hancing viral binding to cells. Nevertheless, after either virus infection
or RNA transfection into Neuro-2a cells, recombinant virus containing
VP2149M and VP1145E mutations might be propagated and cause RNA
accumulation increase due to high binding ability of 4643 VP2149M+
VP1145E virus to cells. To assess RNA accumulation directly, we used
Neuro-2a cell extract-based in vitro translation/replication approach,
as an additional method to test cooperatively enhanced effect of
VP2149M and VP1145E mutations. When 4643 RNA combining with
various capsid protein mutations were added to in vitro translation/
replication reaction, 4643 VP2149M+VP1145E RNA also showed
Fig. 3.Methionine in VP2149 and glutamic acid in VP1145 co-contribute to MP4 virus infectivity and cytotoxicity. (a) Schematic diagram of recombinant EV71 with various single or
double mutations. Neuro-2a cells were infected with recombinant viruses at moi of 0.1 for ﬁve days. Virus infectivity and cytotoxicity were determined as described in Fig. 2. Results
displayed infectivity (b) and cytotoxicity (c) of recombinant viruses in Neuro-2a cells, data expressed as mean±SD of each group (n=3).
136 S.-W. Huang et al. / Virology 422 (2012) 132–143twice the RNA increase as 4643 RNA (Fig. 6d), similar to results of
virus infection (Fig. 6a) and RNA transfection (Fig. 6c). By contrast,
no obvious rise in RNA was observed from 4643 VP2149M or VP1145E
RNA in vitro translation-replication, indicating presence of such mu-
tations might further aid increase of viral RNA besides enhancing
viral binding to cells.
To determine whether VP2149M and VP1145E mutations heightened
viral RNA accumulation in trans as well, capsid protein coding region
P1 carrying each mutation was engineered into pEGFP-C1 vectors,
then transfected into Neuro-2a cells to express various capsid poly-
proteins with or without mutation. For P1 polyprotein production,
at 24 h post-transfection, plasmid-transfected Neuro-2a cells were
supertransfected with EV71 5LNS3 replicon RNA, which included an
entire 5′UTR, luciferase and P2–P3 polyprotein coding region and 3′
UTR. Luciferase activity was determined after harvest at 8-hour
post-supertransfection. Capsid polyprotein with single mutation-
expressing cells (4643 VP2149M or 4643 VP1145E) exhibited no higher
luciferase activity from EV71 5LNS3 replicon RNA than 4643 capsid-
expressing cells (Fig. 7a). When mutations were co-introduced, cap-
sid polyprotein (4643 VP2149M+VP1145E) mutant expression cells
displayed signiﬁcantly greater luciferase activity. To examine capsidprotein expression, Western blot showed no obvious difference of
P1 protein expression between cells transfected with various mutant
expression plasmids (Supplemental Fig. 4a). This result was consis-
tent with data observed in cis: VP2149M and VP1145E dual mutations
enhanced RNA accumulation in EV71 infection. We suggest VP2149M
and VP1145E mutations contribute to increase of RNA in Neuro-2a
cells not only in cis but also in trans.
To investigate whether 3D polymerase expression was critical to
effect of mutant VP1145E and/or VP2149M in RNA accumulation, we
supertransfected another replicon RNA, 5LNS3 del 3D, which lacked
the major part of 3D polymerase coding region, into various P1 pro-
tein expression cells. With 3D polymerase gene of replicon RNA delet-
ed, no signiﬁcant difference in luciferase activity arose between wild-
type and mutant capsid polyprotein-expressing cells. Unlike 5LNS3
replicon data, no enhanced luciferase activity in capsid polyprotein-
expression cells appeared, regardless of whether VP1145E and/or
VP2149M mutations existed (Fig. 7b). P1 protein expression was con-
sistent among cells transfected with various mutant expression plas-
mids determined by Western blot (Supplemental Fig. 4b). We thus
conclude that capsid proteins with these mutations increased viral
RNA accumulation in a 3D polymerase-dependent manner.
Fig. 4.Methionine in VP2149 and glutamic acid in VP1145 enlarged plaque of MP4. Plaque formed by recombinant viruses with mutations in VP2149, VP1145, or VP1283 residues was
tested on RD cells monolayer with 1% methylcellulose. After four days incubation, cells were ﬁxed with formaldehyde and stained with crystal violet.
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To test whether capsid protein regions determined mouse fatality
of MP4, we intraperitoneally inoculated recombinant viruses de-
scribed above and calculated their 50% lethal dose (LD50) titers in a
one-day-old mouse infection model. Results also demonstrated MP4
capsid protein coding region as determining lethality (Table 2):
MP4 showed high mouse lethality (LD50=101.91) in contrast to
non-lethality of 4643 virus (LD50=10>6.41). Among the 4643 series
of recombinants, only 4M4, containing the capsid protein coding re-
gion from MP4 with other remaining regions from 4643, displayed
substantial low LD50 of 100.88; recombinants, including M44 and
44M, like 4643 virus, did not kill mice (LD50=10>6.71 and 10>6.49,Fig. 5. Contributions of capsid VP2149M and VP1145E mutations to virus binding deter-
mined by ELISA. Recombinant 4643 and MP4 viruses were absorbed into Neuro-2a
cells at 4 °C, bound viruses detected by ELISA with monoclonal anti-EV71 antibody.
Data were expressed as mean±SD of each group (n=4). *** pb0.001, **pb0.01 vs.
the binding ability of 4643 virus.respectively). In MP4 series of recombinant viruses, exchange of
MP4 capsid protein coding region with that of 4643 and remaining re-
gions from MP4 (M4M virus) decreased MP4 mouse lethality
(LD50=10>7.5). Recombinants 4MM and MM4 displayed low LD50
(LD50=102.17 and 101.60, respectively) similar to MP4. Difference be-
tween 4643 and MP4 in the capsid protein coding region determined
mouse lethality in vivo.
Investigation of VP2149M andVP1145Emutations' effect on lethality of
the virus inmice showed 4643 VP2149M or 4643 VP1283S not killingmice
(LD50=10>7.69 and 10>7.79, respectively) during two weeks of obser-
vation; 4643 VP1145E virus showed moderately high lethality of
LD50=103.5. Yet LD50 of 4643 VP1145E was at least 31 times that of
MP4 (101.91). Besides VP1145E mutation, secondary mutation evidently
contributed to MP4 lethality in vivo. Virus infectivity and cytotoxicity
portended VP2149M and VP1145E mutation cooperatively increasing in-
fectivity, resulting in high cytotoxicity of recombinant 4643 virus in
vitro. In a mouse infection model in vivo, our results presented 4643
virus containing both mutations (4643 VP2149M+VP1145E) as showing
low mouse LD50 of 102. Contrary ﬁnding was obtained by recombinant
MP4 virus containing converse mutations. VP1145Q (MP4 VP1145Q,
LD50=10>7.35) dramatically reduced mouse lethality of MP4
(LD50=101.91). MP4 VP2149K virus exhibited moderate mouse lethality
(LD50=105.75), while MP4 VP1283F exhibited low LD50 of 102.58 close to
MP4 wild type. In short, mouse model comparison proved amino acid
glutamate at VP1145 as essential for mouse lethality, and methionine
at VP2149 can synergistically increase effect of VP1145E.
Fig. 8 plots viral infectivity (pfu yield ﬁve days post-infection from
Neuro-2a cells) and cytotoxicity in vitro versusmouse lethality in vivo.
Most recombinant viruses (4643, 44M, M44, 4643 VP2149M, 4643
VP1283S, MP4 VP1145Q, and MP4 VP2149K+VP1145Q) that displayed
high LD50 (>106) in vivo exhibited low infectivity in vitro. Conversely,
recombinants with low LD50 (b104) namely MP4, 4M4, 4MM, MM4,
4643 with VP2149M and VP1145E mutations, and MP4 with VP1283F
mutation in vivo, exhibited high infectivity in vitro (Fig. 8a). In a sim-
ilar scenario, cytotoxicity of these recombinants emanating from their
viral infectivity in vitro generally correlated with their lethal outcome
in vivo (Fig. 8b). Overall, EV71 mouse lethality correlated with viral
infectivity (r2=0.4929, p=0.0024) and cytotoxicity (r2=0.6687,
Fig. 6. Contribution of mutant capsid VP2149M and VP1145E to RNA accumulation. Recombinant 4643 viruses with mutations were infected in Neuro-2a cells at moi of 100. In contrast
to 18S ribosomal RNA, viral RNA accumulation change was derived by qRT-PCR (a), burst size of viruses by plaque assay (b). (c) Recombinant 4643 RNA with these mutations were
transfected into Neuro-2a cells. Accumulation of these RNAs was determined by qRT-PCR. (d) Various recombinant RNA were added to in vitro translation/replication reactions and
RNA amounts examined by qRT-PCR. Data were expressed as mean±SD of each group (n=3). *pb0.05, **pb0.01, ***pb0.001 vs. 4643 virus or RNA group.
138 S.-W. Huang et al. / Virology 422 (2012) 132–143p=0.0001), suggesting high viral infectivity yielding high cytotoxicity
in vitromight contribute to higher mouse lethality in vivo.
Discussion
EV71 is highly neurotropic, seen as re-emerging enterovirus after
eradication of poliovirus (McMinn, 2002). Shahar et al. proved that
encephalitic viruses like Sindbis and Theiler induce severe cytotoxic-
ity and demyelination due to rapid viral replication in both neurons
and all glial cell types; non-encephalitic strains like West Nile and ra-
bies viruses mainly replicate in neurons at a much slower rate, caus-
ing only mild lesion to cells and myelin sheath (Shahar et al., 1992).
Prior study found mouse-adapted MP4 strain to induce more neuro-
nal cell apoptosis than parental 4643 strain (Wang et al., 2004). Our
data here show VP2149M and VP1145E dual mutations cooperatively in-
creasing either viral infectivity in mouse neuroblastoma Neuro-2a
cells in vitro or mouse lethality in vivo. Accompanied by raised viral
binding ability to Neuro-2a cells, dual mutations synergistically en-
hance EV71 RNA accumulation not only in cis and in trans but also
in a 3D polymerase-dependent manner. Taken together, these sug-
gest dual capsid protein substitution promoting EV71 adaptation in
mice, presumably arising from enhanced binding ability and RNA ac-
cumulation by VP2149M and VP1145E.
Prior study showed several substitutions located in various re-
gions in MP4 virus sequences (Wang et al., 2004). Here we demon-
strated VP1145E substitutions as critical to mouse-adapted EV71 to
infect mice in intra peritoneal infection model in vivo. Our results con-
cur with Arita, et al. and Chua, et al.: i.e., mouse pathogenesis of EV71
apparently rising in the presence of VP1145E mutation (Arita et al.,2008; Chua et al., 2008). Their earlier reports found this mutation
causing paralysis in inoculated mice and conferring mouse lethality
phenotype (Arita et al., 2008; Chua et al., 2008). Recently, a mouse
muscle-adapted EV71 strain containing the same VP1145E mutation
showed severe necrotizing myositis in skeletal and cardiac muscles,
plus intestinitis in mice (Wang et al., 2011). Glutamic acid, most com-
mon amino acid at VP1145 among human isolates, and glycine or glu-
tamine was less seen at this position. Many EV71 isolates were
isolated from throat or rectal swab specimens instead of brain or
CNS tissue. Human isolates may have reduced neurovirulence and
obtained amino acid residues other than glutamic acid. Hence,
through passages in brain tissue of mice in probes by Arita, et al.
and Chua, et al. as well as our study, EV71 might retrieve VP1145E sub-
stitution and regain increasedmouse lethality. Similarly, through pas-
sages in muscle tissue of mice investigations by Wang, et al., EV71
might retrieve many mutations, including VP1145E substitution, and
heighten mouse virulence. In the ﬁrst step of enterovirus infection,
we believe that icosahedrally symmetric capsid bound to the cellular
receptor and released viral RNA into cytoplasm for replication (Colston
and Racaniello, 1995; Liao and Racaniello, 1997). In this case, substitu-
tions in capsid proteins possibly changed binding ability of propagated
viruses to target cells and affected viral infectivity. Virus binding ability
assay results showed VP1145 residue substitution from polarized and
uncharged glutamine to non-polarized negative charged glutamic acid
increasing virus growth and absorption of virus in mouse neuroblasto-
ma Neuro-2a cell infection. VP1145E mutation also shows reduction of
EV71 binding ability to human cell line RD opposite to our recent data
in mouse Neuro-2a cells, possibly due to diverse receptor structure or
heterogenous receptor usage (Arita et al., 2008). Hence, glutamic acid
Fig. 7. Contribution of capsid VP2149M and VP1145E mutations to virus replication in
trans. Neuro-2a cells transiently expressed capsid P1 polyprotein with VP2149M and/
or VP1145E mutations were supertransfected by 5LNS3 (a) or 5LNS3 del 3D (b) replicon
RNA. RNA accumulation was gauged by luciferase activity after cell harvest, data
expressed as mean±SD of each group (n=3).
Fig. 8. Correlation between viral infectivity and cytotoxicity in vitro andmouse lethality
in vivo. Mouse lethality (50% lethal doses in neonatal mice intraperitoneal infection)
versus (a) viral infectivity (pfu yield at ﬁve days post-infection from Neuro-2a cells)
and (b) cytotoxicity (proportions of apoptotic Neuro-2a cells at ﬁve days post-
infection) of recombinant viruses were plotted. Results with 50% lethal doses >106
were plotted as “>6”.
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resulting virulence increase in vivo. Besides elevating virus binding by
VP1145E as an essential mutation for mouse virulence, enhancing RNA
accumulation by VP2 and VP1 mutations might contribute to virus
propagation, resulting increased virulence in vivo (Fig. 6). We consid-
ered that increased virus binding was critical for virulence, and in-
creased RNA accumulation enhanced this effect on virulence in mice.
Until now, two EV71 receptors, human P-selectin glycoprotein
ligand-1 (PSGL-1) and scavenger receptor Class B Member 2 (SCARB2),Table 2
50% lethal dose (LD50) of 4643 and MP4 recombinant viruses.
Recombinant viruses LD50 (log pfu) Recombinant viruses LD50 (log pfu)
4643 >6.41 4643 VP2149M >7.69
MP4 1.91 4643 VP1145E 3.50
4MM 2.17 4643 VP1283S >7.79
M44 >6.71 4643 VP2149M VP1145E 2.00
44M >6.49 MP4 VP2149K 5.75
MM4 1.60 MP4 VP1145Q >7.35
4M4 0.88 MP4 VP1283F 2.58
M4M >7.50 MP4 VP2149K VP1145Q >9.27were identiﬁed (Nishimura et al., 2009; Yamayoshi et al., 2009). Nishi-
mura et al. reported PSGL-1 as one vital EV71 receptor to infect T cell
line (Nishimura et al., 2009). Comparison of EV71 strains showed gluta-
mic acid of VP1145 as one of four amino acid changes (Ile of VP355, Lys of
VP198, and Ile of VP1262) contributing to PSGL-1 binding ability of EV71
virus, auguring a key role for VP1145 in virus-cell receptor interaction;
glutamic acid at this residue likely enhanced viral infectivity and lethali-
ty. VP1145 was identiﬁed as positive selection site in EV71 evolution
(Chen et al., 2010; Huang et al., 2009). Under selective pressure in herd
immunity, it exhibited as non-synonymousmutationwith high frequen-
cy non-synonymous mutation rates among EV71 strains, portending
VP1145 as antigenic site of neutralizing antibody against EV71 infection
or adaptation for circulation in the population (Huang et al., 2009). It is
thus suggested VP1145 playing roles in not only virus-receptor interac-
tion but also EV71 evolution.
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bly via raising virus binding ability to cellular receptor,we demonstrated
hydrophobic amino acid methionine at VP2149 residue synergistically
augmenting mouse lethality with VP1145E. Similarly, recombinant 4643
viruses with VP2149M mutation, such as 4643 VP2149M and 4643
VP2149M+VP1145E, presented higher virus titers in Neuro-2a cells. Our
data showed contribution of VP2149 residue to EV71 infection in
mouse cells as consistentwith other reports showing contribution of hy-
drophobic amino acid isoleucine residue in VP2149 residue to viral
growth in CHO cells (Chua et al., 2008). A more recent study demon-
strates expression of PSGL-1 in mouse cells resulting in conversion of
VP1 145 to glutamine and VP2 149 lysine to isoleucine or methionine
(Miyamura et al., 2010). Our results prove VP2149M virus grows robustly
in Neuro-2a cells, yet this virus shows 4643 binding and RNA accumula-
tion characteristics. In our unpublished analysis, we characterized RNA
release ability among VP2 and VP1 mutant viruses into Neuro-2a cells.
We found VP2149M mutation, not VP1145E mutation, enhanced virus
RNA release into Neuro-2a cells (unpublished result). Moreover, both
VP2149M and VP2149M+VP1145E mutations increased virus titers
(Fig. 6b and Supplemental Fig. 3), and viral protein expression (Supple-
mental Fig. 2) in Neuro-2a cells; however, 4643 VP2149M virus did not
replicate as fast as 4643 VP2149M+VP1145E virus (Supplemental
Fig. 3). In enterovirus infection, virus robustly replicated in cells, then ac-
cumulated a great quantity of de novo synthesized viral proteins includ-
ing known viral apoptosis-inducing proteins 2A (Kuo et al., 2002) and
3C proteases (Li et al., 2002). Consequently, these proteases activated
caspase cascades and degraded cellular DNA in nucleosomes, both hall-
marks of apoptosis. We thus suggest that 4643 VP2149M infection
showed signiﬁcantly high percentage of EV71(+)/Annexin V(−) cells
at Days 4 and 5 but did not quickly reach sufﬁcient viral proteins to in-
duce apoptosis. Prolonged time may be needed for 4643 VP2149M to ac-
cumulate enough viral protein to induce apoptosis.
In our results, VP2149M showed no obvious enhancement effect on
virus binding ability; it is possible that VP2149M and VP1145E dual muta-
tions raised mouse lethality via an alternative way. RNA transfection
and in vitro translation/replication data of Neuro-2a cells indicated
VP2149M and VP1145E dual mutations exhibiting greater RNA accumula-
tion. Aside from increasing RNA accumulation by RNA transfection
(Fig. 6c), we examined RNA amounts of replicon by luciferase activity
in capsid polyprotein-expressing Neuro-2a cells. Results showed great-
er luciferase activity in VP2149M and VP1145E mutant capsid protein ex-
pression cells (Fig. 7). On the basis of cell-based experiment and in vitro
translation/replication assay, we suggest these dual mutations as ade-
quate forMP4 virus to raise EV71 infectivity in vitro andmouse lethality
in vivo via not only virus binding ability to cellular receptors but also
greater RNA accumulation. Among human EV71 isolates, lysine oc-
curredmost often at VP2149 (a total of 315 isolates), but only onemethi-
onine and three isoleucine residues at this position were found in the
sequences of human EV71 isolates published in Genbank database.
Whether isolates manifest enhanced viral replication and lead to more
virulent EV71 should be further investigated.
We likewise saw capsid protein with VP1145E or VP2149M mutation
enhancing luciferase activity of replicon in trans and effects of VP1145E
and VP2149M mutations enhancing EV71 RNA accumulation as 3Dpol-
dependent. Moreover, VP2149M and VP1145E mutations contributed to
RNA accumulation in Neuro-2a and RD cells, meaning the scenario
might be consistent within various cell types, albeit not in a type-
speciﬁc manner. To our knowledge, there are two possible explana-
tions for these mutations raising RNA accumulation: less degradation
of or more production of RNA. First, stabilization of RNA within viral
capsid protein might protect viral RNA from degradation (Newman
et al., 1995; Verheyden et al., 2001). These stabilization mechanisms
of viral RNAmay prevent degradation by nuclease activity and elevate
RNA accumulation. Second, enterovirus 3D polymerase synthesized
viral RNA with functional replication complex located on the mem-
brane of virus-induced vesicles in cytoplasm during viral RNAreplication (Egger et al., 1996). Dissociation of these vesicles showed
viral structural capsid proteins and nonstructural proteins like 3D po-
lymerase as associated with RNA in the replication complex (Egger et
al., 1996). Other than 3D polymerase, capsid protein 14S pentamer
was found associated with nonstructural 2B and 3D proteins involved
in replication complex, though function of this association between
capsid–capsid or capsid–nonstructural protein interaction remains
unclear. Replicon results showed VP2149M and VP1145E mutations
augmenting RNA accumulation in a 3Dpol-dependent manner, sug-
gesting that these mutations might be involved in RNA replication
too. Hence it was considered that VP2149M and VP1145E mutations di-
rectly or indirectly alter RNA-proteins or viral protein–cellular pro-
tein interaction while increasing RNA stability and production,
promoting RNA accumulation. As cited above, localization of identi-
ﬁed EV71 receptors PSGL-1 and SCARB2 were not exclusive to the
brain and neurotropism of EV71, which hinted other receptor or un-
known cellular factors may contribute to EV71 infection (Nishimura
et al., 2009; Patel and Bergelson, 2009; Yamayoshi et al., 2009). In
this scenario, our results that found enhanced effects of VP2149M
and VP1145E mutations on RNA accumulation in mouse neuronal
cells may offer another possible view for EV71 neurotropism. Substi-
tutions were suggested to change cellular interaction between viral or
cellular factors and raise RNA accumulation of EV71 in infected neu-
rons. We examined these sites in capsid protein structure by homol-
ogy remodeling ((PS)2, http://ps2.life.nctu.edu.tw/). Both VP2149
and VP1145 were exposed on the external loop of capsid proteins
(Supplemental Fig. 5). This possible inﬂuence on RNA accumulation
might enhance viral replication and pathogenesis of EV71 in neurons,
though viral and/or cellular factors and how these determine RNA ac-
cumulation increase remained to be investigated.
Besides capsid genes, mutations in untranslated and non-
structural regions of enterovirus might also change viral biological
properties and its virulence. In a poliovirus study, mutations in highly
conserved regions 5′-UTR, 3D, and 3′-UTR acting together or individ-
ually affected temperature susceptibility (Arita et al., 2005). Introduc-
ing TS determinants of Sabin 1 into EV71 BrCr-TR strain also caused
defective viral replication in non-permissive temperature. EV71 dem-
onstrated strong temperature-sensitive phenotype resulting from tri-
ple mutations, Y73H, C363I in 3D and A7049G in 3′-UTR (Arita et al.,
2005). They found PV1 and EV71 sharing common genetic determi-
nant of temperature sensitivity; the whole genome EV71 might be re-
sponsible for a portion of the effect. Besides capsid protein coding
region contributing to infectivity and mouse lethality of EV71, we
think other regions like 5′-UTR and non-structural region also affect
viral traits. When comparing infectivity of recombinant M44 and
4643 virus, we noticed 5′-UTR of MP4 increasing 4643 virus infectiv-
ity, while comparison of infectivity between M4M and 44M yielded
no difference. One explanation: 5′-UTR, the capsid region, and non-
structural region might affect viral infectivity, albeit not in an abso-
lutely independent manner. Besides correlation between infectivity
in neuron cells in vitro and mouse lethality in vivo, other EV71 ge-
nome regions apart from capsid genes might also contribute to infec-
tivity and mouse lethality. Moreover, most recombinant viruses,
exhibiting low infectivity in vitro, displayed high LD50 (>106)
in vivo; those containing VP2149M mutation (4643 VP2149M) and
M44 exhibited relatively high infectivity in vitro and high LD50
(>106) in vivo. In contrast to virus growth, cytotoxicity of these
recombinants seems more correlated with virulence of these viruses
in vivo (Fig. 8b). Statistical analysis in Figs. 8a and b indicated correla-
tion between in vivo virulence and cytotoxicity (r2=0.6687), which
showed higher r2 value than that between in vivo virulence and
virus growth (r2=0.4929). We thus suggest that correlation with in
vivo virulence were more prominently relevant to apoptosis than to
virus growth.
In sum, we established a mouse-adapted EV71 infectious clone sys-
tem to study mouse adaptation of EV71 and plotted correlation
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We also showed capsid proteins of MP4 contributing to viral infectivity
in mouse neurons in vitro. Moreover, EV71 viruses with VP2149M and
VP1145E mutations in the capsid region heightened viral infectivity
resulting in cytotoxicity in vitro and mouse lethality in vivo, possibly
by increasing virus binding activity and RNA accumulation of EV71.
Materials and methods
Cells and viruses
RD (human rhabdomyosarcoma), Vero (African green monkey
kidney epithelium cells), and A549 (human lung carcinoma) (Biore-
source Collection and Research Center, Taiwan) were maintained in
Dulbecco's modiﬁed Eagle's medium; Neuro-2a (mouse neuroblasto-
ma) cells (American Type Culture Collection, Manassas, VA) kept in
Minimal Eagle's medium alpha, containing 10% fetal bovine serum
plus 2 mM L-glutamine, 100 IU of penicillin, and 100 μg of streptomy-
cin per ml. To prepare stocks, viruses were propagated in RD cells for
one more passage in RD cells, titer determined by plaque assay in RD
cells described previously (Kung et al., 2010).
Construction of infectious cDNA clones
RNA puriﬁcation of 4643 and MP4 virus were performed by using
QIAmp Viral RNA kit (QIAGEN). After extraction of virus RNA, cDNA
was synthesized using EV71 speciﬁc primers (Supplemental Table
1) and SuperScript II (Life Technologies) as recommended by the
manufacturer. Synthesized cDNA was treated by RNase H (Life Tech-
nologies) and RNase T1 and stored at−20 °C. To construct the infec-
tious cDNA clones of different EV71 isolates, synthesized cDNA served
as template for PCR, using primer pairs by KOD plus DNA polymerase
(TOYOBO), as detailed earlier (Kung et al., 2010). PCR products were
extracted from gel, extended a nucleotide by Taq DNA polymerase
extendase activity (New England BioLabs) and cloned into TOPO vec-
tor using TOPO XL PCR cloning kit (Invitrogen). Speciﬁc primers
designed based on published EV71 sequences, were used for com-
plete genome sequencing of these cDNA constructs (Huang et al.,
2009; Yan et al., 2001). Accession numbers of 4643 andMP4 cDNA se-
quences were JN544418 and JN544419, respectively.
To engineer serials of 4643 and MP4 recombinant virus constructs
with genome region replacements, those three DNA fragments con-
taining EV71 sequences corresponding to nt 1 to 964, 965 to 3351
and 3352 to 7411 were digested by one of the restriction enzyme
pairs, including NotI and BbvCI, BbvCI and BspEI, or BspEI and MluI
(New England Biolabs) from 4643 and MP4 infectious clones, respec-
tively (Fig. 2a). By T4 DNA ligase (TAKARA), digested fragments from
4643 cDNA clone were individually ligated to the respective MP4
cDNA fragments whose corresponding regions were removed by the
same enzyme pair. Conversely, those fragments from MP4 cDNA
clones were ligated to the remaining 4643 cDNA as well. Finally,
these series of ligated chimeric cDNAs contained either 4643 cDNA
with a corresponding region replaced by MP4 cDNA or MP4 cDNA
with a corresponding region replacement by 4643 cDNA. To construct
infectious cDNA with various mutations, site-directed mutagenesis
was performed by overlapping PCR using speciﬁc designed primers
(Supplemental Table 1). Using wild-type infectious cDNA as template,
amplicons were obtained by sense primer BbvCI-F (5′-catcttcact-
gaaatg gcagcgccattaaaatctccatctgctgagg-3′) and anti-sense primer
3655-R (5′-ccctggttccgaat gacccactgcaagcatgaga-3′) paired with
anti-sense and sense mutagenesis primers designed for 4643 and
MP4 mutations at nt. position 1398 (at VP2149 residue), 2873 (at
VP1145 residue) and 3288 (at VP1283 residue), respectively. After pu-
riﬁcation of amplicons, respective fragments were overlapped, ex-
tended, and ampliﬁed by BbvCI-F and 3655-R primers. Ampliﬁed
mutant fragments were cloned into pGEM-T easy vector (Promega)and introduced into the capsid protein coding region corresponding
to EV71 nt 965 to 3351 region of 4643 andMP4 infectious cDNAs. Mu-
tant 4643 and MP4 infectious cDNAs with corresponding mutations
were used for in vitro and in vivo analysis.
To transient express the P1polyprotein inNeuro-2a cells, the plasmids
including pEGFP-4643 (4643), pEGFP-4643 VP2149M (4643 VP2149M),
pEGFP-4643 VP1145E (4643 VP1145E), and pEGFP-4643 VP2149M+
VP1145E (4643 VP2149M+VP1145E) that contained P1 polyprotein with
respective mutations were constructed. HindIII and BamHI fragment
was ampliﬁed by sense 4643P1-HindIII-F (5′-tcaagcttcgatgggctca
caagtgtccacacaacgctccgg-3′) and anti-sense MP4P1-BamHI-R (5′-
ggtggatccttattagag ggtggtgattgctgtgcgactggcacc-3′) primers using wild
type or mutant 4643 cDNAs as templates. These amplicons with corre-
sponding mutations were cloned into pEGFP-C1 (Clontech) vector by
using HindIII and BamHI digestion. These resultant plasmids were used
for trans-RNA replication analysis.
In vitro transcription and RNA transfection
All EV71 cDNA constructs were digested with MluI to produce
DNA template, puriﬁed by phenol/chloroform extraction, ethanol pre-
cipitation and then dissolved in RNase-free water. For in vitro RNA
transcription reaction, 5 μg of linear DNA template were added to a
T7 RNA polymerase reaction of RiboMax™ large scale RNA production
systems (Promega Corporation, USA) in total volume of 25 μl. Tran-
scription reaction was terminated by adding 5 U of RQ1 RNase-free
DNase (Promega cooperation, USA) and incubated at 37 °C for
30 min, then puriﬁed by phenol/chloroform. Two microgram RNA
was transfected into 4×105 RD cells in six well plates by using Trans-
Messenger Transfection Reagent (QIAGEN) for virus propagation and
recombinant viruses were harvested on post-transfection day 3 or 4
until cytopathic effect was observed on more than 75% cells.
Examination of virus titer and apoptosis
Neuro-2a cell, RD, Vero, and A549 cell monolayers were infected
with various EV71 recombinants atmoi of 0.1, described above. Infected
Neuro-2a cells were harvested at different intervals, and whole-cell ly-
sates were prepared for plaque assay to determine virus titers after
freeze and thaw once. On 1 (RD), 2 (Vero) and 5 days post-infection
(Neuro-2a and A549), EV71-infected cells were stained with FITC-
conjugated Annexin V (BD Pharmingen). Apoptotic cells were exam-
ined by ﬂow cytometer (BD Immunocytometry Systems).
Virus binding assay
To examine virus binding ability by ELISA, 2×104 cells/well of
Neuro-2a were seeded in 96-well plate for 2 days. The cells were
washed with PBS, and various recombinant 4643 with mutations
were added to cells at moi of 20 for 1-hour incubation at 4 °C. Un-
bound virus was washed out of cells with iced PBS. Cells were ﬁxed
by 80% acetone and stained with monoclonal antibody against EV71
(MAb 979, Millipore) at 1:2000 dilution in 1% BSA for 1 h. This was
followed by washing with PBS-T (0.05% Tween 20 in PBS) and stain-
ing with peroxidase conjugated goat polyclonal antibody to mouse
IgG (Cell Signaling) at a 1:2000 dilution in 1% BSA for 1 h. Once
washed with PBS-T, freshly prepared substrate 3,3′,5,5′-TetraMethyl-
Benzidine (100 μl) (Invitrogen) was added to each well and absorp-
tion measured at 450 nm.
Examination of RNA accumulation
To examine RNA accumulation by high moi infection, 105 cells/
well Neuro-2a cells were seeded in 12-well plate and infected with
various recombinant 4643 viruses at moi 100. Total cell lysates were
harvested, virus titers determined by plaque assay. To ascertain RNA
142 S.-W. Huang et al. / Virology 422 (2012) 132–143accumulation, 105 cells/well Neuro-2a were seeded in 12 well plates.
After overnight incubation, Neuro-2a cells were infected with recom-
binant 4643 viruses at moi of 100. At indicated times, cells were
scraped and total RNA were extracted by Total RNA Extraction kit
(Geneaid) to determine viral RNA and 18S ribosomal RNA copies by
qRT-PCR as described (Marino et al., 2003; Rabenau et al., 2002).
Folds change of viral RNA/18S ribosomal RNA were calculated in con-
trast to 0 h post-infection. To determine the RNA accumulation by
RNA transfection, 105 cells/well of RD and Neuro-2a were seeded in
12 well plate for 1 and 2 days, respectively. The recombinant 4643
RNA were then transfected into RD and Neuro-2a cells by TransMes-
senger Transfection Reagent (QIAGEN) as recommended by the man-
ufacturer. At indicated times, cells were scraped and total RNA were
extracted by Total RNA Extraction kit (Geneaid) to determine viral
RNA copies by qRT-PCR. Fold increase of RNA copies was calculated
in contrast to 0 h post-transfection.
Effect of RNA accumulation in trans
For transient expression of P1 polyprotein, 105 cells/well of
Neuro-2a were seeded in 12-well plate. A total of 2 μg of pEGFP-
4643 (4643), pEGFP-4643 VP2149M (4643 VP2149M), pEGFP-4643
VP1145E (4643 VP1145E), and pEGFP-4643 VP2149M+VP1145E (4643
VP2149M+VP1145E) plasmids and 8 μl Metafectene (Biontex) in
100 μl PBS were incubated for 24 h, respectively. After incubation,
1.6 μg 5LNS3 RNA, 3.2 μl Enhancer, and 6 μl Transmessenger reagent
(QIAGEN) were mixed and added to Neuro-2a cells, as recommended
by the manufacturer. EV71 RNA accumulation was shown by measur-
ing luciferase activities of 5LNS3 and 5LNS3 del 3D replicon, as de-
scribed previously (Kung et al., 2010). After 3 h incubation,
transfected cells were washed by 1 ml PBS and then harvested by
200 μl passive lysis buffer (Promega) at 8 h post-transfection. Lucifer-
ase activities of 20 μl cell lysate were examined by Luciferase assay
system (Promega) according to the manufacturer's instruction.
In vitro translation/replication of EV71 RNA
Neuro-2a extract and Neuro-2a cell initiation factors were prepared
by the method described previously (Barton et al., 1995; Brown and
Ehrenfeld, 1979). Neuro-2a cells were maintained in 15 cm culture
dishes, rather than suspension culture. As conﬂuence (approximately
109 cells), cells were treated with 0.05% trypsin–0.02% EDTA and resus-
pended in PBS. After harvest by centrifugation, cell pellets were washed
three times with isotonic buffer [35 mM HEPES (N-2-hydroxyethylpi-
perazine-N′-2-ethanesulfonic acid) (pH 7.4), 146 mMNaCl, 11 mMglu-
cose] and centrifuged in 50 ml tubes. Thereafter, the pellet was
resuspended in 1.5 volumes of hypotonic buffer [20 mM HEPES (pH
7.4), 10 mM KCl, 1.5 mM Mg(CH3CO2)2, 1 mM dithiothreitol (DTT)]
and incubated for 10 min on ice for further homogenization and prepa-
ration, as described previously (Barton and Flanegan, 1993).
Neuro-2a translation-replication reaction mix (50 μl) contained
25 μl Neuro-2a extract, 10 μl Neuro-2a cell initiation factors, 5 μl 10X
nucleotide mixture [10 mM ATP, 2.5 mM GTP, 2.5 mM CTP, 2.5 mM
UTP, 600 mM KCH3CO2, 300 mM creatine phosphate, 4 mg/ml crea-
tine kinase, and 155 mM HEPES-KOH (pH 7.4)], 1.25 μg various
EV71 RNA, 20 U RNAsin, and 20 mM amino acids. Reaction mix was
incubated at 30 °C for 6 h and sequentially centrifuged at 15,000 g
at 4 °C for 15 min. The pellet was resuspended in 50 μl reaction mix-
ture [50 mM HEPES (pH 8.0), 3 mM MgCl2, 10 mM DTT, 0.5 mM each
NTP (ATP, GTP, CTP, and UTP), and additional 2 mM guanidine hydro-
chloride in control groups] and incubated at 30 °C for 2 h. RNA
amount in reaction mixture was determined by qRT-PCR after viral
RNA extraction. Adding guanidine hydrochloride inhibited virus
RNA replication, change of RNA copies was calculated by (RNA
amount without addition of guanidine hydrochloride)/(RNA amount
with addition of guanidine hydrochloride).In vivo mouse model
Speciﬁc pathogen-free, ICR mice (new born, the Laboratory Animal
Center, National Cheng Kung University) were intraperitoneally inocu-
lated with 100 μl (i.p.) of different EV71 viruses indicated. Control ani-
mals were given medium instead of virus. Animals were observed
daily for weight gain or loss, and mortality until 14 days post-
infection. The Institutional Animal Care and Use Committee approved
all animal protocols.
Statistical analysis
The apoptosis, virus binding, RNA amount, and luciferase activity
values between groups were statistically analyzed by the one-way
ANOVA test. The results are expressed as means±standard deviation
of the means (SD) from one representative experiment. A p value of
b0.05 was considered to be signiﬁcant.
Supplementary materials related to this article can be found on-
line at doi:10.1016/j.virol.2011.10.015.
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